# VIYASH share price, delivery % and history — Viyash Scientific Limited

> Delivery percentage for Viyash Scientific Limited (VIYASH) against its own history, with 2,612 sessions of split-adjusted NSE data from 2016 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/VIYASH

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 235.8 INR (-0.95% on the day), 2026-09-30
- Delivery: 50.94% of volume taken to demat (20-day average 54.38%)
- Volume: 12.49L shares, turnover ₹29.5Cr
- Relative volume: 0.47× of its own 20-day average

## Technicals

- RSI(14): 34.28
- ATR(14): 8.43
- SMA 50: 258.58, SMA 200: 231.94
- 52-week range: 178.13 – 298 (-20.87% from the high)

## Performance

- 1 week -7.07%, 1 month -10.55%, 3 months -19.37%
- 6 months 25.76%, 1 year 15.92%

## Delivery percentage

- Latest: 50.94% (2026-09-30)
- 20-day average: 54.38%
- 1-year average: 49.89%
- Percentile against its own history: 69th
- Range: 5.32% – 100% across 1,728 sessions with a reading

Over the last 20 sessions VIYASH settled 54.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 49.9%, so recent sessions are running 4.5 points higher than usual. The latest session ranks higher than 69% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 10,413.6 crore
- P/E (TTM): 48.71 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 4.84 INR, split-adjusted to match the price series
- Revenue growth: 114.39% YoY, 2.87% QoQ
- Profit growth: 351.28% YoY, 19.45% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 48.56% | 289% |
| 3y | 30.62% | — |
| 4y | 21.74% | 66.22% |
| 5y | 17.82% | 19.64% |
| 6y | 17.26% | 15.25% |
| 7y | 16.48% | 17.86% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 368.7 | 360.9 | 7.9 | 6.3 | 0.1 | 1.72% |
| 2024-12-31 | 390.8 | 388.2 | 8.1 | 6.5 | 0.14 | 1.66% |
| 2025-03-31 | 401.7 | 386.7 | 16.3 | 10.4 | 0.37 | 2.58% |
| 2025-06-30 | 441.4 | 418.5 | 25.5 | 17.6 | 0.57 | 3.98% |
| 2025-09-30 | 424 | 397.3 | 27.2 | 19.6 | 0.59 | 4.62% |
| 2025-12-31 | 858.4 | 758.1 | 73.1 | 48.5 | 0.89 | 5.65% |
| 2026-03-31 | 920 | 810.6 | 125.2 | 66.4 | 1.2 | 7.22% |
| 2026-06-30 | 946.4 | 842.3 | 112.4 | 79.3 | 1.51 | 8.38% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 61.31%
- Public: 38.6%
- FII: 4.5%, DII: 3.75%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-11: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_185200_11082026175634_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697280_20072026061916_WEB.xml
- 2026-05-19: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_159092_19052026221835_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1656342_21042026044705_WEB.xml
- 2026-02-05: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_140680_05022026211714_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1607231_21012026050424_WEB.xml
- 2025-12-23: shareholding for 2025-12-16 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1589083_23122025060053_WEB.xml
- 2025-11-14: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_128488_14112025212437_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 74 events are indexed for this instrument.

## About the instrument

- Listed: 2016-03-10 — latest session 2026-09-30 (2,612 sessions)
- ISIN: INE807F01027
- Series: EQ
- Liquidity rank: #395 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/VIYASH.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.